Home/PK MED/Charles Sanson, PhD

CS

Charles Sanson, PhD

Head of Research & Development

Therapeutic Areas

Rheumatology Hematology Musculoskeletal Disorders

PK MED Pipeline

Drug	Indication	Phase
PKM-01	Gout Flare	Phase 2
PKM-011	Osteoarthritis	Pre-clinical
PKM-02	Hemoglobinopathies (e.g., via HSCT enhancement)	Pre-clinical

Leadership Team at PK MED

Gauthier Pouliquen, PhD

Chief Executive Officer

Vincent Dagommer

Chief Financial Officer

Farah Marzouki, Eng., MSc

Head of Pharmaceutical Development

Julien Grassot, PhD

Head of Biostatistics and Clinical Development

Dr. Philippe Pouletty

Chairman of the Board

View full PK MED profile